TIGIT modulates sepsis-induced immune dysregulation in mice with preexisting malignancy
TIGIT is a recently identified coinhibitory receptor that is upregulated in the setting of cancer and functionally contributes to the impairment of antitumor immunity. However, its role during sepsis is unknown. Because patients with cancer are 10 times more likely to die of sepsis than previously h...
Main Authors: | Wenxiao Zhang, Jerome C. Anyalebechi, Kimberly M. Ramonell, Ching-wen Chen, Jianfeng Xie, Zhe Liang, Deena B. Chihade, Shunsuke Otani, Craig M. Coopersmith, Mandy L. Ford |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2021-06-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.139823 |
Similar Items
-
The IL-27 receptor regulates TIGIT on memory CD4+ T cells during sepsis
by: Kristen N. Morrow, et al.
Published: (2021-02-01) -
Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously naive hosts
by: Yini Sun, et al.
Published: (2021-03-01) -
IL-17, IL-27, and IL-33: A Novel Axis Linked to Immunological Dysfunction During Sepsis
by: Kristen N. Morrow, et al.
Published: (2019-08-01) -
CD8+ T cells are necessary for improved sepsis survival induced by CD28 agonism in immunologically experienced mice
by: Jerome C. Anyalebechi, et al.
Published: (2024-04-01) -
Pre-existing malignancy results in increased prevalence of distinct populations of CD4+ T cells during sepsis.
by: Jianfeng Xie, et al.
Published: (2018-01-01)